Starling Oncology (STLNW) Interest Coverage Ratio (2021 - 2026)
Starling Oncology's (STLNW) quarterly Interest Coverage Ratio came in at 2.48 in Q2 2026, up 58.58% on a YoY basis from 1.57 in Q2 2025, and up 26.27% quarter-over-quarter from 3.37 in Q1 2026.
Powered by 
Analysis
Starling Oncology (STLNW) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Starling Oncology (STLNW) has reported Interest Coverage Ratio for 6 consecutive years, with 2.48 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest Coverage Ratio rose 58.58% year-over-year to 2.48; the trailing twelve-month figure through Jun 2026 stood at 3.42 (up 21.01% YoY), and the FY2025 full-year result was 3.2, up 60.1% from the prior year.
- Interest Coverage Ratio rose to 2.48 in Q2 2026 per STLNW's latest filing, from 3.37 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1.78 in Q1 2025 and bottomed at 300.07 in Q2 2022.
- Historically, Interest Coverage Ratio has averaged 41.95 across 5 years, with a median of 7.73 in 2024.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio plunged 2077.9% in 2022, then jumped 96.96% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 300.07 in 2022, then soared by 97.38% to 7.88 in 2023, then declined by 29.67% to 10.21 in 2024, then jumped by 64.7% to 3.6 in 2025, then soared by 31.12% to 2.48 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.48, 3.37, and 3.6 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 3.85 |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 2.17 |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 4.78 |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | - |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | - |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 6.97 |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | - |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | - |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | 6.83 |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | -2.48 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.48 |
| Mar 31, 2026 | -3.37 |
| Dec 31, 2025 | -3.60 |
| Sep 30, 2025 | -4.19 |
| Jun 30, 2025 | -6.00 |
| Mar 31, 2025 | -1.78 |
| Dec 31, 2024 | -10.21 |
| Sep 30, 2024 | -6.23 |
| Jun 30, 2024 | -7.73 |
| Mar 31, 2024 | -9.05 |
| Dec 31, 2023 | -7.88 |
| Sep 30, 2023 | -7.93 |
| Jun 30, 2023 | -9.12 |
| Jun 30, 2022 | -300.07 |
| Mar 31, 2022 | -249.61 |
| Jun 30, 2021 | -13.78 |
| Mar 31, 2021 | -17.36 |